An overview of chronic lymphocytic leukaemia biology

Best Practice and Research: Clinical Haematology

Volumn 23, Issue 1, 2010, Pages 21-32

  Bertilaccio, M T S ^a   Scielzo, C ^a,c   Muzio, M ^a   Caligaris Cappio, F ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

B cell receptor; microenvironment; mouse models

Indexed keywords

ANTINEOPLASTIC AGENT; B LYMPHOCYTE RECEPTOR; BREAKPOINT CLUSTER REGION PROTEIN; CALCIUM ION; CD19 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN; CD31 ANTIGEN; CD38 ANTIGEN; CD40 LIGAND; CD5 ANTIGEN; CD69 ANTIGEN; CD71 ANTIGEN; CD79B ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; FC RECEPTOR IIB; FLUDARABINE; IMMUNOGLOBULIN D; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MICRORNA; PROTEIN BCL 2; PROTEIN KINASE ZAP 70; STROMAL CELL DERIVED FACTOR 1; UNINDEXED DRUG;

ANTIGEN RECOGNITION; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BIOACCUMULATION; C57BL 6 MOUSE; CALCIUM TRANSPORT; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DELETION 13; CHRONIC LYMPHATIC LEUKEMIA; CLONAL ANERGY; DRUG EFFICACY; ENHANCER REGION; EXPERIMENTAL MODEL; GENETIC DISORDER; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA CELL; MOLECULAR BIOLOGY; MOUSE STRAIN; NEW ZEALAND BLACK MOUSE; NEW ZEALAND WHITE MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RNA GENE; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR MICROENVIRONMENT; XENOTRANSPLANTATION;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;

EID: 77956643987     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2009.12.005     Document Type: Review

References (107)

1. P. Ghia, and F. Caligaris-Cappio The origin of B-cell chronic lymphocytic leukemia Semin Oncol 33 2 2006 Apr 150 156
2. U. Klein, Y. Tu, G.A. Stolovitzky, M. Mattioli, G. Cattoretti, and H. Husson Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells J Exp Med 194 11 2001 Dec 3 1625 1638
3. R.N. Damle, F. Ghiotto, A. Valetto, E. Albesiano, F. Fais, and X.J. Yan B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes Blood 99 11 2002 Jun 1 4087 4093
4. A.S. Freedman, A.W. Boyd, F.R. Bieber, J. Daley, K. Rosen, and J.C. Horowitz Normal cellular counterparts of B cell chronic lymphocytic leukemia Blood 70 2 1987 Aug 418 427
5. F. Caligaris-Cappio, M. Gobbi, M. Bofill, and G. Janossy Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia J Exp Med 155 2 1982 Feb 1 623 628
6. T.W. LeBien, and T.F. Tedder B lymphocytes: how they develop and function Blood 112 5 2008 Sep 1 1570 1580
7. I. Forster, and K. Rajewsky Expansion and functional activity of Ly-1 + B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice Eur J Immunol 17 4 1987 Apr 521 528
8. K.M. Ansel, R.B. Harris, and J.G. Cyster CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity Immunity 16 1 2002 Jan 67 76
9. K.M. Haas, J.C. Poe, D.A. Steeber, and T.F. Tedder B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae Immunity 23 1 2005 Jul 7 18
10. I. Forster, H. Gu, W. Muller, M. Schmitt, D. Tarlinton, and K. Rajewsky CD5 B cells in the mouse Curr Top Microbiol Immunol 173 1991 247 251
11. A.M. Stall, M.C. Farinas, D.M. Tarlinton, P.A. Lalor, L.A. Herzenberg, and S. Strober Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals Proc Natl Acad Sci U S A 85 19 1988 Oct 7312 7316
12. J. LeMaoult, S. Delassus, R. Dyall, J. Nikolic-Zugic, P. Kourilsky, and M.E. Weksler Clonal expansions of B lymphocytes in old mice J Immunol 159 8 1997 Oct 15 3866 3874
13. A. Kantor A new nomenclature for B cells Immunol Today 12 11 1991 Nov 388
14. P. Youinou, C. Jamin, and P.M. Lydyard CD5 expression in human B-cell populations Immunol Today 20 7 1999 Jul 312 316
15. N. Chiorazzi, and M. Ferrarini B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor Annu Rev Immunol 21 2003 841 894
16. H.H. Wortis, M. Teutsch, M. Higer, J. Zheng, and D.C. Parker B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes Proc Natl Acad Sci U S A 92 8 1995 Apr 11 3348 3352
17. F.K. Stevenson, and F. Caligaris-Cappio Chronic lymphocytic leukemia: revelations from the B-cell receptor Blood 103 12 2004 Jun 15 4389 4395
18. S. Stilgenbauer, P. Lichter, and H. Dohner Genetic features of B-cell chronic lymphocytic leukemia Rev Clin Exp Hematol 4 1 2000 Mar 48 72 (Pubitemid 34947478)
19. F.R.O.M.A. Caligaris-Cappio illuminates CLL genomic lesions Blood 113 6 2009 Feb 5 1209 1210
20. V. Grubor, A. Krasnitz, J.E. Troge, J.L. Meth, B. Lakshmi, and J.T. Kendall Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA) Blood 113 6 2009 Feb 5 1294 1303
21. S. Stilgenbauer, and H. Dohner Molecular genetics and its clinical relevance Hematol Oncol Clin North Am. 18 4 2004 Aug 827 848 viii
22. G.A. Calin, C.D. Dumitru, M. Shimizu, R. Bichi, S. Zupo, and E. Noch Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc Natl Acad Sci U S A 99 24 2002 Nov 26 15524 15529
23. A. Cimmino, G.A. Calin, M. Fabbri, M.V. Iorio, M. Ferracin, and M. Shimizu miR-15 and miR-16 induce apoptosis by targeting BCL2 Proc Natl Acad Sci U S A 102 39 2005 Sep 27 13944 13949
24. M. Ruzzene, A.M. Brunati, S. Sarno, O. Marin, A. Donella-Deana, and L.A. Pinna Ser/Thr phosphorylation of hematopoietic specific protein 1 (HS1): implication of protein kinase CK2 Eur J Biochem 267 10 2000 May 3065 3072
25. J.A. Burger, P. Ghia, A. Rosenwald, and F. Caligaris-Cappio The microenvironment in mature B-cell malignancies: a target for new treatment strategies Blood 2009 Jul 27
26. C. Calissano, R.N. Damle, G. Hayes, E.J. Murphy, M.K. Hellerstein, and C. Moreno In vivo intra- and inter-clonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia Blood 2009 Sep 29
27. F. Caligaris-Cappio Role of the microenvironment in chronic lymphocytic leukaemia Br J Haematol 123 3 2003 Nov 380 388
28. B.T. Messmer, E. Albesiano, D.G. Efremov, F. Ghiotto, S.L. Allen, and J. Kolitz Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia J Exp Med 200 4 2004 Aug 16 519 525
29. J.A. Burger, N. Tsukada, M. Burger, N.J. Zvaifler, M. Dell'Aquila, and T.J. Kipps Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1 Blood 96 8 2000 Oct 15 2655 2663
30. A.V. Kurtova, K. Balakrishnan, R. Chen, W. Ding, S. Schnabl, and M.P. Quiroga Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance Blood 2009 Sep 17
31. S. Deaglio, A. Capobianco, L. Bergui, J. Durig, F. Morabito, and U. Duhrsen CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells Blood 102 6 2003 Sep 15 2146 2155
32. N. Chiorazzi, K. Hatzi, and E. Albesiano B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens Ann N Y Acad Sci 1062 2005 Dec 1 12
33. S.J. Richardson, C. Matthews, M.A. Catherwood, H.D. Alexander, B.S. Carey, and J. Farrugia ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL) Blood 107 9 2006 May 1 3584 3592
34. R.S. Stark, L.F. Liebes, M.L. Shelanski, and R. Silber Anomalous function of vimentin in chronic lymphocytic leukemia lymphocytes Blood 63 2 1984 Feb 415 420
35. F. Caligaris-Cappio, L. Bergui, L. Tesio, G. Corbascio, F. Tousco, and P.C. Marchisio Cytoskeleton organization is aberrantly rearranged in the cells of B chronic lymphocytic leukemia and hairy cell leukemia Blood 67 1 1986 Jan 233 239
36. G.S. Nowakowski, J.D. Hoyer, T.D. Shanafelt, C.S. Zent, T.G. Call, and N.D. Bone Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia J Clin Oncol 27 11 2009 Apr 10 1844 1849
37. A.G. Ramsay, A.J. Johnson, A.M. Lee, G. Gorgun, R. Le Dieu, and W. Blum Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug J Clin Invest 118 7 2008 Jul 2427 2437
38. M. Vicente-Manzanares, and F. Sanchez-Madrid Role of the cytoskeleton during leukocyte responses Nat Rev Immunol 4 2 2004 Feb 110 122
39. J.J. Hao, J. Zhu, K. Zhou, N. Smith, and X. Zhan The coiled-coil domain is required for HS1 to bind to F-actin and activate Arp2/3 complex J Biol Chem. 280 45 2005 Nov 11 37988 37994
40. M. Muzio, C. Scielzo, M. Frenquelli, A. Bachi, M. De Palma, and M. Alessio HS1 complexes with cytoskeleton adapters in normal and malignant chronic lymphocytic leukemia B cells Leukemia 2007 May 17
41. Y.R. Carrasco, S.J. Fleire, T. Cameron, M.L. Dustin, and F.D. Batista LFA-1/ICAM-1 interaction lowers the threshold of B cell activation by facilitating B cell adhesion and synapse formation Immunity 20 5 2004 May 589 599
42. S.J. Fleire, J.P. Goldman, Y.R. Carrasco, M. Weber, D. Bray, and F.D. Batista B cell ligand discrimination through a spreading and contraction response Science 312 5774 2006 May 5 738 741
43. S. Deaglio, T. Vaisitti, S. Aydin, L. Bergui, G. D'Arena, and L. Bonello CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential Blood 110 12 2007 Dec 1 4012 4021
44. C. Scielzo, P. Ghia, A. Conti, A. Bachi, G. Guida, and M. Geuna HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses J Clin Invest 115 6 2005 Jun 1644 1650
45. T.N. Hartmann, V. Grabovsky, W. Wang, P. Desch, G. Rubenzer, and S. Wollner Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow Cancer Res. 69 7 2009 Apr 1 3121 3130
46. T.J. Hamblin, Z. Davis, A. Gardiner, D.G. Oscier, and F.K. Stevenson Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia Blood 94 6 1999 Sep 15 1848 1854
47. K. Stamatopoulos, C. Belessi, C. Moreno, M. Boudjograh, G. Guida, and T. Smilevska Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations Blood 109 1 2007 Jan 1 259 270
48. L.Z. Rassenti, L. Huynh, T.L. Toy, L. Chen, M.J. Keating, and J.G. Gribben ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia N Engl J Med 351 9 2004 Aug 26 893 901
49. M. Crespo, F. Bosch, N. Villamor, B. Bellosillo, D. Colomer, and M. Rozman ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia N Engl J Med 348 18 2003 May 1 1764 1775 (Pubitemid 36514707)
50. T.J. Hamblin, J.A. Orchard, A. Gardiner, D.G. Oscier, Z. Davis, and F.K. Stevenson Immunoglobulin V genes and CD38 expression in CLL Blood 95 7 2000 Apr 1 2455 2457
51. J. Durig, M. Naschar, U. Schmucker, K. Renzing-Kohler, T. Holter, and A. Huttmann CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia Leukemia 16 1 2002 Jan 30 35
52. S. Zupo, L. Isnardi, M. Megna, R. Massara, F. Malavasi, and M. Dono CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis Blood 88 4 1996 Aug 15 1365 1374
53. C. Scielzo, A. Camporeale, M. Geuna, M. Alessio, A. Poggi, and M.R. Zocchi ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage Leukemia 20 4 2006 Apr 689 695
54. L. Chen, G. Widhopf, L. Huynh, L. Rassenti, K.R. Rai, and A. Weiss Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia Blood 100 13 2002 Dec 15 4609 4614
55. S. Lanham, T. Hamblin, D. Oscier, R. Ibbotson, F. Stevenson, and G. Packham Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia Blood 101 3 2003 Feb 1 1087 1093
56. R.N. Damle, S. Temburni, C. Calissano, S. Yancopoulos, T. Banapour, and C. Sison CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells Blood 110 9 2007 Nov 1 3352 3359
57. S. Deaglio, T. Vaisitti, R. Billington, L. Bergui, P. Omede, and A.A. Genazzani CD38/CD19: a lipid raft-dependent signaling complex in human B cells Blood 109 12 2007 Jun 15 5390 5398
58. C.M. Lau, C. Broughton, A.S. Tabor, S. Akira, R.A. Flavell, and M.J. Mamula RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement J Exp Med 202 9 2005 Nov 7 1171 1177
59. M. Ehlers, H. Fukuyama, T.L. McGaha, A. Aderem, and J.V. Ravetch TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE J Exp Med 203 3 2006 Mar 20 553 561
60. A. Lanzavecchia, and F. Sallusto Toll-like receptors and innate immunity in B-cell activation and antibody responses Curr Opin Immunol 19 3 2007 Jun 268 274
61. M. Muzio, M.T. Bertilaccio, G. Simonetti, M. Frenquelli, and F. Caligaris-Cappio The role of Toll-like receptors in chronic B cell malignancies Leuk Lymphoma 2009 Aug 11 1 8
62. Y.J. Liu, D.E. Joshua, G.T. Williams, C.A. Smith, J. Gordon, and I.C. MacLennan Mechanism of antigen-driven selection in germinal centres Nature 342 6252 1989 Dec 21-28 929 931
63. C. Buske, G. Gogowski, K. Schreiber, M. Rave-Frank, W. Hiddemann, and B. Wormann Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand Exp Hematol 25 4 1997 Apr 329 337
64. L. Granziero, P. Ghia, P. Circosta, D. Gottardi, G. Strola, and M. Geuna Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia Blood 97 9 2001 May 1 2777 2783
65. L. Granziero, P. Circosta, C. Scielzo, E. Frisaldi, S. Stella, and M. Geuna CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5 + B lymphocytes Blood 101 5 2003 Mar 1 1962 1969
66. E.A. Ranheim, and T.J. Kipps Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal J Exp Med 177 4 1993 Apr 1 925 935
67. S. Kitada, J.M. Zapata, M. Andreeff, and J.C. Reed Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia Br J Haematol 106 4 1999 Sep 995 1004
68. D. Wang, G.J. Freeman, H. Levine, J. Ritz, and M.J. Robertson Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies Br J Haematol 97 2 1997 May 409 417
69. G. Pizzolo, M. Chilosi, A. Ambrosetti, G. Semenzato, L. Fiore-Donati, and G. Perona Immunohistologic study of bone marrow involvement in B-chronic lymphocytic leukemia Blood 62 6 1983 Dec 1289 1296
70. P. Ghia, G. Guida, S. Stella, D. Gottardi, M. Geuna, and G. Strola The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression Blood 101 4 2003 Feb 15 1262 1269
71. I. Ringshausen, F. Schneller, C. Bogner, S. Hipp, J. Duyster, and C. Peschel Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta Blood 100 10 2002 Nov 15 3741 3748
72. A. Sainz-Perez, H. Gary-Gouy, A. Portier, F. Davi, H. Merle-Beral, and P. Galanaud High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia Leukemia 20 3 2006 Mar 498 504
73. S.B. Gauld, J.M. Dal Porto, and J. Cambier B Cell Antigen Receptor Sci STKE (Connections Map Pathway) Avaliable at: http://stke.sciencemag.org/cgi/cm/ stkecm;CMP-6909 2002
74. P.G. Longo, L. Laurenti, S. Gobessi, A. Petlickovski, M. Pelosi, and P. Chiusolo The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease Leukemia 21 1 2007 Jan 110 120
75. A. Rodriguez, N. Martinez, F.I. Camacho, E. Ruiz-Ballesteros, P. Algara, and J.F. Garcia Variability in the degree of expression of phosphorylated IkappaBalpha in chronic lymphocytic leukemia cases with nodal involvement Clin Cancer Res. 10 20 2004 Oct 15 6796 6806
76. A. Contri, A.M. Brunati, L. Trentin, A. Cabrelle, M. Miorin, and L. Cesaro Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis J Clin Invest 115 2 2005 Feb 369 378
77. K. Schuh, A. Avots, H.P. Tony, E. Serfling, and C. Kneitz Nuclear NF-ATp is a hallmark of unstimulated B cells from B-CLL patients Leuk Lymphoma 23 5-6 1996 Nov 583 592
78. R.R. Furman, Z. Asgary, J.O. Mascarenhas, H.C. Liou, and E.J. Schattner Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells J Immunol 164 4 2000 Feb 15 2200 2206
79. M. Muzio, B. Apollonio, C. Scielzo, M. Frenquelli, I. Vandoni, and V. Boussiotis Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy Blood 112 1 2008 Jul 1 188 195
80. K.T. Merrell, R.J. Benschop, S.B. Gauld, K. Aviszus, D. Decote-Ricardo, and L.J. Wysocki Identification of anergic B cells within a wild-type repertoire Immunity 25 6 2006 Dec 953 962
81. J.I. Healy, R.E. Dolmetsch, L.A. Timmerman, J.G. Cyster, M.L. Thomas, and G.R. Crabtree Different nuclear signals are activated by the B cell receptor during positive versus negative signaling Immunity 6 4 1997 Apr 419 428
82. S.C. Wong, W.K. Chew, J.E. Tan, A.J. Melendez, F. Francis, and K.P. Lam Peritoneal CD5 + B-1 cells have signaling properties similar to tolerant B cells J Biol Chem. 277 34 2002 Aug 23 30707 30715
83. S.B. Gauld, R.J. Benschop, K.T. Merrell, and J.C. Cambier Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling Nat Immunol 6 11 2005 Nov 1160 1167
84. C.I. Mockridge, K.N. Potter, I. Wheatley, L.A. Neville, G. Packham, and F.K. Stevenson Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status Blood 2007 Jan 25
85. J.A. Phillips, K. Mehta, C. Fernandez, and E.S. Raveche The NZB mouse as a model for chronic lymphocytic leukemia Cancer Res. 52 2 1992 Jan 15 437 443
86. A.M. Brunati, M. Ruzzene, P. James, B. Guerra, and L.A. Pinna Hierarchical phosphorylation of a 50-kDa protein by protein tyrosine kinases TPK-IIB and C-Fgr, and its identification as HS1 hematopoietic-lineage cell-specific protein Eur J Biochem 229 1 1995 Apr 1 164 170
87. S. Costinean, N. Zanesi, Y. Pekarsky, E. Tili, S. Volinia, and N. Heerema Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice Proc Natl Acad Sci U S A 103 18 2006 May 2 7024 7029
88. E.S. Raveche, E. Salerno, B.J. Scaglione, V. Manohar, F. Abbasi, and Y.C. Lin Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice Blood 2007 Mar 9
89. E. Salerno, B.J. Scaglione, F.D. Coffman, B.D. Brown, A. Baccarini, and H. Fernandes Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity Mol Cancer Ther 8 9 2009 Sep 2684 2692
90. X. Wen, D. Zhang, Y. Kikuchi, Y. Jiang, K. Nakamura, and Y. Xiu Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus Eur J Immunol 34 10 2004 Oct 2740 2749
91. B.J. Scaglione, E. Salerno, M. Balan, F. Coffman, P. Landgraf, and F. Abbasi Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model Br J Haematol 139 5 2007 Dec 645 657
92. J.M. Zapata, M. Krajewska, H.C. Morse 3rd, Y. Choi, and J.C. Reed TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice Proc Natl Acad Sci U S A 101 47 2004 Nov 23 16600 16605
93. S. Haiat, C. Billard, C. Quiney, F. Ajchenbaum-Cymbalista, and J.P. Kolb Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia Immunology 118 3 2006 Jul 281 292
94. L. Planelles, C.E. Carvalho-Pinto, G. Hardenberg, S. Smaniotto, W. Savino, and R. Gomez-Caro APRIL promotes B-1 cell-associated neoplasm Cancer Cell. 6 4 2004 Oct 399 408
95. Y. Pekarsky, N. Zanesi, R.I. Aqeilan, and C.M. Croce Animal models for chronic lymphocytic leukemia J Cell Biochem 100 5 2007 Apr 1 1109 1118
96. R. Bichi, S.A. Shinton, E.S. Martin, A. Koval, G.A. Calin, and R. Cesari Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression Proc Natl Acad Sci U S A 99 10 2002 May 14 6955 6960
97. X.J. Yan, E. Albesiano, N. Zanesi, S. Yancopoulos, A. Sawyer, and E. Romano B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia Proc Natl Acad Sci U S A 103 31 2006 Aug 1 11713 11718
98. A.J. Johnson, D.M. Lucas, N. Muthusamy, L.L. Smith, R.B. Edwards, and M.D. De Lay Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia Blood 108 4 2006 Aug 15 1334 1338
99. Q.L. Wu, I.N. Buhtoiarov, P.M. Sondel, A.L. Rakhmilevich, and E.A. Ranheim Tumoricidal effects of activated macrophages in a mouse model of chronic lymphocytic leukemia J Immunol 182 11 2009 Jun 1 6771 6778
100. C. Holler, J.D. Pinon, U. Denk, C. Heyder, S. Hofbauer, and R. Greil PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia Blood 113 12 2009 Mar 19 2791 2794
101. T. Enzler, A.P. Kater, W. Zhang, G.F. Widhopf 2nd, H.Y. Chuang, and J. Lee Chronic lymphocytic leukemia of E{micro}-TCL1 transgenic mice undergoes rapid cell-turnover that can be offset by extrinsic CD257 to accelerate disease progression Blood 2009 Sep 15
102. P.J. ter Brugge, V.B. Ta, M.J. de Bruijn, G. Keijzers, A. Maas, and D.C. van Gent A mouse model for chronic lymphocytic leukemia based on expression of the SV40 large T antigen Blood 114 1 2009 Jul 2 119 127
103. J.L. Hummel, B.D. Lichty, M. Reis, I. Dube, and S. Kamel-Reid Engraftment of human chronic lymphocytic leukemia cells in SCID mice: in vivo and in vitro studies Leukemia 10 8 1996 Aug 1370 1376
104. A. Shimoni, H. Marcus, B. Dekel, R. Shkarchi, F. Arditti, and L. Shvidel Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human->mouse radiation chimera Cancer Res. 59 23 1999 Dec 1 5968 5974
105. J. Durig, P. Ebeling, F. Grabellus, U.R. Sorg, M. Mollmann, and P. Schutt A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease Cancer Res. 67 18 2007 Sep 15 8653 8661
106. A. Stacchini, M. Aragno, A. Vallario, A. Alfarano, P. Circosta, and D. Gottardi MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation Leuk Res. 23 2 1999 Feb 127 136
107. B.T. Messmer, D. Messmer, S.L. Allen, J.E. Kolitz, P. Kudalkar, and D. Cesar In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells J Clin Invest 115 3 2005 Mar 755 764